[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100553789":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":25,"locations":24,"responsibleParty":31,"collaborators":24,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":24,"eligibilityCriteria":41,"healthyVolunteers":37,"sex":42,"minAge":43,"maxAge":24,"enrollmentInfo":44,"targetDuration":24,"studyType":47,"phases":48,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":57,"whyStopped":24,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":24},{"fullName":5,"class":6},"Ankara Ataturk Sanatorium Training and Research Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Tranexamic acid","ACTIVE_COMPARATOR","Patients will be asked to clean their nose with tap water as part of the routine treatment before the administration. After then, Tranexamic acid (500mg\u002F5 ml) will be sprayed through the bleeding side nostril and then external pressure will be applied to the nose for 10 minutes.",[13],"Drug: Blood Stopper (Ankaferd)",{"label":15,"type":16,"description":17,"interventionNames":18},"Blood Stopper (Ankaferd)","EXPERIMENTAL","Patients will be asked to clean their noses with tap water as part of the routine treatment before the administration. After then, 5 ml of Ankaferd® will be sprayed through the bleeding side nostril and external nasal pressure will be performed for 10 minutes.",[13],[20],{"type":21,"name":15,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","5 ml of Ankaferd® will be sprayed through the bleeding side nostril and external nasal pressure will be performed for 10 minutes.",[15,9],null,[26],{"name":27,"role":28,"phone":29,"phoneExt":24,"email":30},"Şeref Kerem Çorbacıoğlu, Professor","CONTACT","+905437656176","serefkeremcorbacioglu@gmail.com",{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Şeref Kerem Çorbacıoğlu","Emergency Medicine Department","100553789","phase-4-tranexamic-acid-versus-blood-stopper-treatments-in-epistaxis-management-100553789",false,"NCT06490653","Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management","Comparison of the Efficacy of Tranexamic Acid and Blood Stopper Treatments in Bleeding Control in Patients With Epistaxis: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients over 18 years of age with epistaxis will present to the emergency department with non-traumatic epistaxis and whose bleeding do not stop with simple external compression for 10 minutes.\n\nExclusion Criteria:\n\n* Patients demonstrating hemodynamic instability\n* Patients with documented allergy to tranexamic acid or Ankaferd\n* patients with known bleeding disorders,\n* patients using anticoagulants,\n* pregnant patients","ALL","18 Years",{"count":45,"type":46},186,"ESTIMATED","INTERVENTIONAL",[49],"PHASE4","In this randonmized controlled trial, aim to compare the effectiveness of local administration of tranexamic acid and blood stopper (Ankaferd®) on cessation of bleeding in epistaxis patients.",[52],"Epistaxis Nosebleed",[54,55,56,9],"Epistaxis","Nosebleed","Ankaferd","NOT_YET_RECRUITING","2024-06-29",{"date":60,"type":61},"2024-07-08","ACTUAL",{"date":63,"type":46},"2024-10",{"date":65,"type":46},"2025-12",{"name":5,"class":6}]